Literature DB >> 10451692

Directly observed therapy (DOT) for tuberculosis: why, when, how and if?

L P Ormerod1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10451692      PMCID： PMC1765927          DOI： 10.1136/thx.54.2008.s42

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  28 in total

1.  The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis.

Authors:  W FOX
Journal:  Tubercle       Date:  1958-10

2.  What makes DOT work? Directly observed therapy.

Authors:  P Garner
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

3.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

4.  Tuberculous chemotherapy for recalcitrant outpatients administered directly twice weekly.

Authors:  J A Barbaro; S Johnson
Journal:  Am Rev Respir Dis       Date:  1968-05

5.  Compliance: inducements and enforcements.

Authors:  J A Sbarbaro
Journal:  Chest       Date:  1979-12       Impact factor: 9.410

6.  Compliance of patients and physicians: experience and lessons from tuberculosis-I.

Authors:  W Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

7.  Compliance of patients and physicians: experience and lessons from tuberculosis-II.

Authors:  W Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-09

8.  New responsibilities for health departments and public health nurses in tuberculosis-- keeping the outpatient on therapy.

Authors:  T Moulding
Journal:  Am J Public Health Nations Health       Date:  1966-03

9.  A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States.

Authors:  B L Davidson
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

10.  Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China.

Authors:  J P Cao; L Y Zhang; J Q Zhu; D P Chin
Journal:  Int J Tuberc Lung Dis       Date:  1998-05       Impact factor: 2.373
View more
  4 in total

1.  Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand.

Authors:  Pimwara Tanvejsilp; Mark Loeb; Jonathan Dushoff; Feng Xie
Journal:  Pharmacoecon Open       Date:  2018-09

2.  Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.

Authors:  Anna Zaczek; Anna Brzostek; Ewa Augustynowicz-Kopec; Zofia Zwolska; Jaroslaw Dziadek
Journal:  BMC Microbiol       Date:  2009-01-15       Impact factor: 3.605

3.  A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

4.  Determinants of self-management behaviors among pulmonary tuberculosis patients: a path analysis.

Authors:  Jin Li; Jie Pu; Jiaqing Liu; Qingya Wang; Rui Zhang; Ting Zhang; Jiani Zhou; Wei Xing; Shengxiang Liang; Daiyu Hu; Ying Li
Journal:  Infect Dis Poverty       Date:  2021-07-30       Impact factor: 4.520
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.